system: You are a contract-analysis assistant performing a span-extraction task. You are given an excerpt from a commercial contract and the name of a clause type to locate within it.

Return the exact text of the requested clause, copied verbatim from the excerpt — identical wording and punctuation, with no paraphrasing, summarising, explanation, or added commentary.

The excerpt is one window of a much longer contract and often will not contain the requested clause. If the requested clause does not appear in this excerpt, respond with exactly: Not found.

Output only the extracted clause text, or the exact string `Not found.` — nothing else.

user: Contract excerpt:
"""
Exhibit 10.14 [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. MANUFACTURING AND SUPPLY AGREEMENT DATED AS OF January 1, 2013 BETWEEN VAPOTHERM, INC. AND MEDICA, S.p.A. TABLE OF CONTENTS Page ARTICLE 1 SALE AND PURCHASE 1 1.1 Supply of Cartridge 1 1.2 [* * *] 1 1.3 Purchase of Cartridge 1 ARTICLE 2 FORECASTS; INVENTORY 1 2.1 Rolling Forecasts 1 2.2 Inventory 2 ARTICLE 3 ORDERS, SHIPMENT, AND PAYMENT 2 3.1 Price 2 3.2 Purchase Orders 2 3.3 Delivery 3 3.4 [* * *] 3 3.5 Delay in Delivery 3 3.6 Delivery Default Rights 3 3.7 Invoices and Payment Terms 3 3.8 Delay in Payment 4 ARTICLE 4 QUALITY OF THE CARTRIDGE 4 4.1 Conformity with Specifications 4 4.2 Conditions to Rejection 4 4.3 Rejection 4 4.4 Nonconformity Default Rights 5 4.5 Acceptance of Cartridges 5 4.6 Quality Monitoring 5 ARTICLE 5 PRODUCTION PROCESS 5 5.1 Joint Review Committee 5 5.2 Process Development 5 5.3 Inventory of Raw Materials and Spare Parts 5 5.4 [* * *] 5 -i- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. ARTICLE 6 QUALITY SYSTEM 6 6.1 General Quality Statement 6 6.2 Quality System Changes 6 6.3 Vendor Quality 6 6.4 Vigilance System 6 ARTICLE 7 OTHER OBLIGATIONS OF MEDICA 7 7.1 Debarment Certification 7 7.2 Permits and Certifications 7 7.3 Manufacturing Problems 7 7.4 Insurance 7 ARTICLE 8 INSPECITONS; RECORDS 8 8.1 Notification of Inquiries and Inspections 8 8.2 Access to Medica Facilities and Records 8 8.3 Records 9 ARTICLE 9 CARTRIDGE RECALLS 9 9.1 Cartridge Recalls 9 9.2 Notice of Events that May Lead to Cartridge Recall 9 9.3 Recall Due to Breach By Medica 9 9.4 Definition of Recall 9 9.5 Recall Process 10 ARTICLE 10 PUBLICITY; CONFIDENTIALITY; INTELLECTUAL PROPERTY 10 10.1 Publicity 10 10.2 Confidentiality 10 10.3 Pre-existing and Independently Developed Intellectual Property 11 10.4 Ownership 11 10.5 [* * *] 11 10.6 Reservation of All Other Rights 11 ARTICLE 11 REPRESENTATIONS 12 11.1 Representations of Medica 12 -ii- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. 11.2 Representations of Vapotherm 13 ARTICLE 12 INDEMNIFICATION 13 12.1 Indemnification 13 12.2 Procedures Relating to Indemnification 14 12.3 No Liability for Consequential Damages 15 12.4 Limitation on Liability 15 ARTICLE 13 TERM AND TERMINATION; BUSINESS CONTINUITY 15 13.1 Term 15 13.2 Termination 16 13.3 Effect of Termination 17 13.4 Business Continuity 17 ARTICLE 14 MISCELLANEOUS 18 14.1 Definitions 18 14.2 Further Assurances 21 14.3 Governing Law 21 14.4 Dispute Resolution 21 14.5 Arbitration 22 14.6 Force Majeure 22 14.7 Assignment 22 14.8 Notices 22 14.9 Severability 23 14.10 Entire Agreement 23 14.11 Amendment 23 14.12 Independent Contractor 23 14.13 Counterparts 23 14.14 Compliance with Laws 24 -iii- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. MANUFACTURING AND SUPPLY AGREEMENT This Manufacturing and Supply Agreement (this "Agreement") is dated January 1st, 2013, between VAPOTHERM, INC., a Maryland corporation ("Vapotherm") and MEDICA S.p.A., an Italian company ("Medica"). WHEREAS, Vapotherm sells systems it has developed for delivering humidified, blended medical gas therapy (the "System"), which system includes a vapor transfer cartridge; WHEREAS, Vapotherm and Medica wish for Medica to manufacture [* * *] (each, a "Cartridge" and collectively, the "Cartridges") for Vapotherm for use in the System, using fiber provided by Medica as developed for the System and packaged as specified in Vapotherm Specification Exhibit D. NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which have hereby acknowledged, the parties therefore agree as follows: ARTICLE 1 SALE AND PURCHASE 1.1 Supply of Cartridge. Subject to the terms of this Agreement, Medica shall manufacture, in such quantities as Vapotherm orders, the Cartridge. 1.2 [* * *] 1.3 Purchase of Cartridge. Subject to the terms of this Agreement, Vapotherm shall purchase from Medica Cartridges following regulatory
"""

Extract the exact clause related to "Notice Period To Terminate Renewal" from the excerpt above.